<DOC>
	<DOCNO>NCT00350155</DOCNO>
	<brief_summary>This study design investigate potential difference GI safety tolerability small bowel lumiracoxib , conventional non-selective NSAID ( naproxen ) proton pump inhibitor ( omeprazole ) , placebo .</brief_summary>
	<brief_title>Video Capsule Endoscopy Investigate Safety Tolerability Lumiracoxib Small Bowel</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Healthy male female subject Evidence cardiovascular , hepatic , gastrointestinal renal disorder Hereditary problem galactose intolerance , severe lactase deficiency glucosegalactose malabsorption syndrome Smokers Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Video capsule endoscopy , healthy volunteer , naproxen , omeprazole , lumiracoxib , small bowel</keyword>
</DOC>